01.07.22
Onera Health introduced its first Onera Biomedical-Lab-on-Chip, an ultra-low-power biosignal sensor hub for wearable health, during CES 2022.
“We are thrilled to introduce Onera Biomedical-Lab-on-Chip in the lead-up to CES 2022 in Las Vegas this week. It’s the perfect opportunity to showcase our chip to the wearables ecosystem,” said Ruben de Francisco, founder and CEO of Onera.
“Our highly integrated and comprehensive biosignal sensor hub is a unique solution that promises to revolutionize this competitive field. It combines clinical-grade physiological measurements and analysis with ultra-low-power consumption, enabling the development of miniaturized and high-quality wearable devices. Launching this powerful chip as a stand-alone product within our portfolio, not just as part of our innovative Onera diagnostic and monitoring solutions, is yet another exciting step for our company,” added de Francisco.
The Dutch-American company leveraged from its tech roots and partnership with imec, a world-leading research and innovation hub in nanoelectronics and digital technologies, with the development of the ultra-low-power biosignal chip.
“Seeing Onera bring this ground-breaking system-on-chip to the market is what imec’s unique experience in semiconductor devices for MedTech applications, and our imec ecosystem, is all about – enabling nano- and digital technology innovation that promises a significant impact on the quality of life,” said Rudi Cartuyvels, COO of imec.
Onera Biomedical-Lab-on-Chip is a multi-channel sensor readout system with integrated data processing, power management, and interfacing features. It offers a wide range of on-chip biomedical sensor readouts, including 10 readouts for ExG, covering EEG, ECG, EMG, and EOG, 2 bioimpedance readouts, and 2 readouts for photoplethysmography.
To support the development and transition to commercialization of Onera’s products, the company has ramped-up hiring recently, including adding to its leadership team.
“We are thrilled to introduce Onera Biomedical-Lab-on-Chip in the lead-up to CES 2022 in Las Vegas this week. It’s the perfect opportunity to showcase our chip to the wearables ecosystem,” said Ruben de Francisco, founder and CEO of Onera.
“Our highly integrated and comprehensive biosignal sensor hub is a unique solution that promises to revolutionize this competitive field. It combines clinical-grade physiological measurements and analysis with ultra-low-power consumption, enabling the development of miniaturized and high-quality wearable devices. Launching this powerful chip as a stand-alone product within our portfolio, not just as part of our innovative Onera diagnostic and monitoring solutions, is yet another exciting step for our company,” added de Francisco.
The Dutch-American company leveraged from its tech roots and partnership with imec, a world-leading research and innovation hub in nanoelectronics and digital technologies, with the development of the ultra-low-power biosignal chip.
“Seeing Onera bring this ground-breaking system-on-chip to the market is what imec’s unique experience in semiconductor devices for MedTech applications, and our imec ecosystem, is all about – enabling nano- and digital technology innovation that promises a significant impact on the quality of life,” said Rudi Cartuyvels, COO of imec.
Onera Biomedical-Lab-on-Chip is a multi-channel sensor readout system with integrated data processing, power management, and interfacing features. It offers a wide range of on-chip biomedical sensor readouts, including 10 readouts for ExG, covering EEG, ECG, EMG, and EOG, 2 bioimpedance readouts, and 2 readouts for photoplethysmography.
To support the development and transition to commercialization of Onera’s products, the company has ramped-up hiring recently, including adding to its leadership team.
